takisbiotech

International Workshop On Autologous Dna -based Antibody Production

We spent a wonderful couple of days in Tours, France, discussing innovative solutions for designing therapeutic antibodies at the International Workshop on Autologous DNA-Based Antibody Production. Our CEO, Luigi Aurisicchio, and our CSO, Giuseppe Roscilli, participated in a synergistic working group aimed at exploring innovative genetic designs, intelligent solutions, and new manufacturing concepts for application […]

4th Consortium Meeting of the MIRIA EU Project in Prague

Last week, our CEO Luigi Aurisicchio attended the 4th Consortium Meeting of the MIRIA EU Project in Prague, hosted by Charles University. Takis, alongside valuable partners from across Europe, holds a central role in this initiative. The MIRIA project aims to develop wide-range antimicrobial nanocoatings for surfaces used in environments such as hospitals, where cross-contamination […]

ANALYSIS OF TUMOR-INFILTRATING BLYMPHOCYTES FOR THE DESIGN OF NEWTHERAPEUTIC STRATEGIES BASED ONSYNTHETIC ANTIBODIES

Tumor-infiltrating lymphocytes (TILs) play a crucial role in regulating tumor progression, with T cells traditionally receiving the most attention. However, recent studies have highlighted the significant contribution of B cells to anti-tumor immunity. Research indicates that high densities of B cells and elevated antibody levels correlate with improved prognoses in various human cancers, including soft […]

AN IN-SILICO DRIVE-THROUGH FOR mAbs DISCOVERY

When monoclonal antibody development intersects with computational science, a groundbreaking collaboration emerges: this is MATCH, or Monoclonal Antibody Development and Characterization Laboratory. Leading this collaboration is our Valerio Chiarini, Ph.D., an expert in structural biology and bioinformatics, and Giuseppe Roscilli, our CTO, as part of the Rome Technopole project. The effort to identify viable candidate […]